Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Esophageal Neoplasms 9Melanoma 6Lung Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Small Cell Lung Carcinoma 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Uterine Cervical Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Transitional Cell 2Unresectable Biliary Tract Cancer 1Thymus Neoplasms 1Thymoma 1Thymic epithelial tumor 1Small Cell Lung Cancer Extensive Stage 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pathologic Complete Response 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Neoplasms 1Muscle-Invasive Bladder Carcinoma 1

Interventions

Radiotherapy 3pembrolizumab 2fludarabine 2Drug Therapy 2Cyclophosphamide 2zimberelimab 1lenvatinib 1envafolimab 1Thymectomy 1Thoracic Surgery, Video-Assisted 1Radiotherapy, Adjuvant 1Proton Therapy 1Paclitaxel 1Methylprednisolone 1Immunotherapy 1Heavy Ion Radiotherapy 1Carboplatin 1Bupivacaine 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thymoma × Immunotherapy × Clear all
NCT05667948 2025-05-22

Molecular Analysis and Treatment Options of Thymic Malignancies

Shanghai Chest Hospital

Recruiting
500 enrolled
Thoracic

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡